PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,000 | -88.9% | 294 | -83.4% | 0.00% | – |
Q3 2019 | $9,000 | -10.0% | 1,772 | -1.5% | 0.00% | – |
Q2 2019 | $10,000 | +25.0% | 1,799 | -1.3% | 0.00% | – |
Q1 2019 | $8,000 | 0.0% | 1,823 | -0.3% | 0.00% | – |
Q4 2018 | $8,000 | -38.5% | 1,828 | -8.1% | 0.00% | – |
Q3 2018 | $13,000 | -31.6% | 1,990 | -18.1% | 0.00% | – |
Q2 2018 | $19,000 | 0.0% | 2,430 | 0.0% | 0.00% | – |
Q1 2018 | $19,000 | +11.8% | 2,430 | -8.2% | 0.00% | – |
Q4 2017 | $17,000 | 0.0% | 2,646 | +20.0% | 0.00% | – |
Q3 2017 | $17,000 | 0.0% | 2,205 | -9.1% | 0.00% | – |
Q2 2017 | $17,000 | -79.5% | 2,426 | -72.4% | 0.00% | -100.0% |
Q1 2017 | $83,000 | +9.2% | 8,780 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $76,000 | +216.7% | 8,780 | +134.2% | 0.00% | – |
Q3 2016 | $24,000 | +100.0% | 3,749 | +33.0% | 0.00% | – |
Q2 2016 | $12,000 | +500.0% | 2,819 | +493.5% | 0.00% | – |
Q1 2016 | $2,000 | -33.3% | 475 | 0.0% | 0.00% | – |
Q4 2015 | $3,000 | 0.0% | 475 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | -62.5% | 475 | -59.6% | 0.00% | – |
Q2 2015 | $8,000 | +60.0% | 1,175 | +46.9% | 0.00% | – |
Q1 2015 | $5,000 | -16.7% | 800 | 0.0% | 0.00% | – |
Q4 2014 | $6,000 | +100.0% | 800 | +44.4% | 0.00% | – |
Q3 2014 | $3,000 | – | 554 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
SEARLE & CO. | 60,000 | $349,000 | 0.34% |
TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |